Higazi Abd Al-Roof, Ajawi Feras, Akkawi Sa'ed, Hess Edna, Kuo Alice, Cines Douglas B
Department of Pathology and Laboratory Medicine, 513A Stellar-Chance, 422 Curie Blvd, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Blood. 2005 Feb 1;105(3):1021-8. doi: 10.1182/blood-2004-03-0995. Epub 2004 Sep 7.
Activation of plasminogen by urokinase plasminogen activator (uPA) plays important roles in several physiologic and pathologic conditions. Cells secrete uPA as a single-chain molecule (scuPA). scuPA can be activated by proteolytic cleavage to a 2-chain enzyme (tcuPA). scuPA is also activated when it binds to its receptor (uPAR). The mechanism by which the enzymatic activity of the scuPA/suPAR complex is regulated is only partially understood. We now report that the plasminogen activator activity of the scuPA/suPAR complex is inhibited by Glu- and Lys-plasminogen, but not by mini-plasminogen. In contrast, neither Glunor Lys-plasminogen inhibits the activation of plasminogen by 2-chain uPA. Inhibition of scuPA/suPAR activity was evident at a Glu-plasminogen concentration of approximately 100 nM, and at physiologic plasma concentrations inhibition was nearly complete. A plasminogen fragment containing kringles 1-3 inhibited the enzymatic activity of scuPA/suPAR with an inhibition constant (Ki) equal to 1.9 microM, increased the Michaelis constant (Km) of scuPA/suPAR from 18 nM to 49 nM, and decreased the catalytic constant (Kcat) approximately 3-fold from 0.035 sec(-1) to 0.011 sec(-1). Inhibition of scuPA/suPAR by plasminogen was completely abolished in the presence of fibrin clots. These studies provide insight into the regulation of uPA-mediated plasminogen activation and identify a novel mechanism for its fibrin specificity.
尿激酶型纤溶酶原激活剂(uPA)激活纤溶酶原在多种生理和病理状况中发挥重要作用。细胞分泌的uPA为单链分子(scuPA)。scuPA可通过蛋白水解裂解激活为双链酶(tcuPA)。scuPA与它的受体(uPAR)结合时也会被激活。scuPA/uPAR复合物酶活性的调节机制仅部分为人所知。我们现在报告,scuPA/uPAR复合物的纤溶酶原激活剂活性受到谷氨酸纤溶酶原和赖氨酸纤溶酶原的抑制,但不受微型纤溶酶原的抑制。相比之下,谷氨酸纤溶酶原和赖氨酸纤溶酶原均不抑制双链uPA对纤溶酶原的激活。在谷氨酸纤溶酶原浓度约为100 nM时,scuPA/uPAR活性的抑制很明显,在生理血浆浓度下抑制几乎是完全的。包含kringles 1 - 3的纤溶酶原片段以1.9 microM的抑制常数(Ki)抑制scuPA/uPAR的酶活性,将scuPA/uPAR的米氏常数(Km)从18 nM提高到49 nM,并使催化常数(Kcat)从0.035秒-1降至0.011秒-1,降低了约3倍。在存在纤维蛋白凝块的情况下,纤溶酶原对scuPA/uPAR的抑制作用完全消除。这些研究为uPA介导的纤溶酶原激活的调节提供了深入了解,并确定了其纤维蛋白特异性的新机制。